781
Participants
Start Date
October 31, 2004
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
ibandronate [Bonviva/Boniva]
3 mg IV every 3 months for 3 years. All patients received a minimum of calcium 500 milligrams/day (upper limit 1500 mg/day) and Vitamin D 400 Internation Units/day (IU/day).
ibandronate [Bonviva/Boniva]
2 mg IV every 2 months for 3 years. All patients received a minimum of calcium 500 milligrams/day (upper limit 1500 mg/day) and Vitamin D 400 Internation Units/day (IU/day).
Budapest
Brussels
Copenhagen
St Leonards
Ballerup Municipality
Sydney
Stavanger
Liège
Haugesund
Vejle
Sommerset West
Cape Town
Aarhus
Aalborg
Mexico City
Berlin
Arenzano
Hamburg
Madrid
Gainesville
Valeggio sul Mincio
Orléans
Essen
Siena
Madison
Fargo
Bismarck
St Louis
Monterrey
Omaha
Lyon
Pilsen
Prague
Oslo
Grudziądz
Krakow
Krakow
Pretoria
Aberdeen
Hoffmann-La Roche
INDUSTRY